MCVEF

Medicover AB MCVEF

Market Closed
7 May, 20:00
OTC PINK OTC PINK
$
12. 25
0
0%
$
2.08B Market Cap
187.67 P/E Ratio
0.13% Div Yield
0 Volume
0 Eps
$ 12.25
Previous Close
Day Range
12.25 12.25
Year Range
10.8 14.73

MCVEF Chart

Medicover AB Profile

Medical Care Facilities Industry
Healthcare Sector
Mr. Fredrik Rågmark CEO
OTC PINK Exchange
- ISIN
US Country
45,316 Employees
29 Apr 2024 Last Dividend
- Last Split
- IPO Date

Overview

Medicover AB (publ) is a healthcare and diagnostic service provider operating out of Stockholm, Sweden, with an extensive international presence, notably in Poland and Sweden. Since its establishment in 1995, the company has grown to offer a broad spectrum of healthcare services tailored to meet the needs of corporate entities, individuals, and public sector entities. Medicover AB is renowned for integrating medical and wellness services, thereby promoting a holistic approach to health care that extends beyond traditional medical treatments.

Products and Services

  • Healthcare Services

    Medicover AB's healthcare services are comprehensive, covering outpatient and inpatient care that ensures patients receive the appropriate level of care for their conditions. They also offer specialized dental services catering to various oral health needs. Beyond medical care, the company provides non-medical related services, including sports memberships, benefit cards, and optics services, as well as wellness services aimed at promoting general health and well-being. Hospital care services focus on providing full-scale hospital treatment, and preventive care services are designed to prevent diseases or detect them at an early stage, minimizing the potential health impact.

  • Diagnostic Services

    Medicover’s diagnostic services offer a wide array of tests essential for accurate diagnoses and effective treatment. These include allergy and autoimmune diagnostics, bacteriology, parasitology, and a comprehensive range of chemistry tests such as biochemistry, immunochemistry, clinical chemistry, and blood group diagnostics/transfusion medicine. Furthermore, they offer diagnostics in tumour markers, cytology, haematology, histopathology, human genetics, hygiene, immunology, and immunochemistry. Their services extend to encompass infectious diseases, microbiology, molecular biology, and pharmacology/toxicology tests, providing a well-rounded diagnostic capability to address a multitude of healthcare needs.

Contact Information

Address: Riddargartan 12A, Stockholm, Sweden, 102 46
Phone: 46 8 40 01 76 00